{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:00:24Z","timestamp":1790370024387,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijrobp.2026.08.001","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:33:53Z","timestamp":1790148833000},"page":"607-615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["More for Some, Less for Others: Refining Treatment for Anorectal Cancers"],"prefix":"10.1016","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7098-9465","authenticated-orcid":false,"given":"Jonathan B.","family":"Ashman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Boldrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishan R.","family":"Jethwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisling","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randa","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Chuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2026.08.001_bib0001","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa2404512","article-title":"Nonoperative management of mismatch repair-deficient tumors","volume":"392","author":"Cercek","year":"2025","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ijrobp.2026.08.001_bib0002","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","article-title":"PDd-1 blockade in mismatch repair-deficient, locally advanced rectal cancer","volume":"386","author":"Cercek","year":"2022","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ijrobp.2026.08.001_bib0003","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S1470-2045(25)00213-X","article-title":"Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): Short-term results of a phase 2 randomised controlled trial","volume":"26","author":"Gilbert","year":"2025","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ijrobp.2026.08.001_bib0004","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1200\/JCO.23.01208","article-title":"Long-term results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: The randomized phase II OPRA trial","volume":"42","author":"Verheij","year":"2024","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ijrobp.2026.08.001_bib0005","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.22.00032","article-title":"Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy","volume":"40","author":"Garcia-Aguilar","year":"2022","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ijrobp.2026.08.001_bib0006","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa2303269","article-title":"Preoperative treatment of locally advanced rectal cancer","volume":"389","author":"Schrag","year":"2023","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ijrobp.2026.08.001_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2025.100807","article-title":"Short-course-based TNT with or without PD-1 inhibitor for PMMR locally advanced rectal cancer: Phase 2 results of a randomized trial (STELLAR II)","volume":"6","author":"Tang","year":"2025","journal-title":"Med."},{"key":"10.1016\/j.ijrobp.2026.08.001_bib0008","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1200\/JCO.21.01667","article-title":"Multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR)","volume":"40","author":"Jin","year":"2022","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ijrobp.2026.08.001_bib0009","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.annonc.2024.06.015","article-title":"Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy in locally advanced rectal cancer (UNION): Early outcomes of a multicenter randomized phase III trial","volume":"35","author":"Lin","year":"2024","journal-title":"Ann Oncol."},{"key":"10.1016\/j.ijrobp.2026.08.001_bib0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.2021.39.3_suppl.8","article-title":"NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC)\u2014pembrolizumab experimental arm primary results","volume":"39","author":"Rahma","year":"2021","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ijrobp.2026.08.001_bib0011","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1200\/JCO.23.02261","article-title":"Randomized phase II trial of immunotherapy-based total neoadjuvant therapy for proficient mismatch repair or microsatellite stable locally advanced rectal cancer (TORCH)","volume":"42","author":"Xia","year":"2024","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ijrobp.2026.08.001_bib0012","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S1470-2045(25)00286-4","volume":"26","author":"Tian","year":"2025","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ijrobp.2026.08.001_bib0013","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, tme, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): A randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ijrobp.2026.08.001_bib0014","doi-asserted-by":"crossref","first-page":"S1163","DOI":"10.1016\/S0167-8140(25)00295-6","article-title":"PRIME-RT: Durvalumab with extended neoadjuvant regimens in locally advanced rectal cancer (LARC): A randomised phase II trial","volume":"206","author":"Roxburgh","year":"2025","journal-title":"Radiother Oncol."},{"key":"10.1016\/j.ijrobp.2026.08.001_bib0015","volume":"44","author":"Song","year":"2026","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ijrobp.2026.08.001_bib0016","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1200\/JCO-25-00731","article-title":"Neoadjuvant chemotherapy with CAPOX versus chemoradiation for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): Final results of a phase III trial","volume":"44","author":"Mei","year":"2026","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ijrobp.2026.08.001_bib0017","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S2468-1253(24)00191-2","article-title":"Optimising local treatment decisions for rectal cancer","volume":"9","author":"Jethwa","year":"2024","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"10.1016\/j.ijrobp.2026.08.001_bib0018","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.annonc.2024.06.019","article-title":"Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: Long-term results of the UNICANCER-PRODIGE 23 trial","volume":"35","author":"Conroy","year":"2024","journal-title":"Ann Oncol."},{"key":"10.1016\/j.ijrobp.2026.08.001_bib0019","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa010580","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer","volume":"345","author":"Kapiteijn","year":"2001","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ijrobp.2026.08.001_bib0020","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaoncol.2019.0186","article-title":"Safety and feasibility of using magnetic resonance imaging criteria to identify patients with \"good prognosis\" rectal cancer eligible for primary surgery: The phase 2 nonrandomized Quicksilver clinical trial","volume":"5","author":"Kennedy","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ijrobp.2026.08.001_bib0021","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1200\/JCO.22.02166","article-title":"Risk-adapted neoadjuvant chemoradiotherapy in rectal cancer: Final report of the OCUM study","volume":"41","author":"Ruppert","year":"2023","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ijrobp.2026.08.001_bib0022","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/SLA.0b013e31820b8d52","article-title":"Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: A prospective, multicenter, European study","volume":"253","author":"Taylor","year":"2011","journal-title":"Ann Surg."},{"key":"10.1016\/j.ijrobp.2026.08.001_bib0023","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1200\/JCO-24-01676","article-title":"Neoadjuvant modified infusional fluorouracil, leucovorin, and oxaliplatin with or without radiation versus fluorouracil plus radiation for locally advanced rectal cancer: Updated results of the FOWARC study after a median follow-up of 10 years","volume":"43","author":"Zhang","year":"2025","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ijrobp.2026.08.001_bib0024","article-title":"Moving beyond anatomy: The future of rectal cancer management is biologically-informed, response-adapted, and patient-centered","volume":"60","author":"Jethwa","year":"2026","journal-title":"Clin Transl Radiat Oncol."},{"key":"10.1016\/j.ijrobp.2026.08.001_bib0025","doi-asserted-by":"crossref","first-page":"S1246","DOI":"10.1016\/S0167-8140(25)01871-7","article-title":"PLATO ACT 4: Long term results of an RCT evaluating reduced dose and standard dose chemoradiotherapy in early-stage anal cancer","volume":"206","author":"Sebag-Montefiore","year":"2025","journal-title":"Radiother Oncol."},{"key":"10.1016\/j.ijrobp.2026.08.001_bib0026","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ijrobp.2026.08.001_bib0027","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/DCR.0000000000001166","article-title":"Patient and physician preferences for nonoperative management for low rectal cancer: Is it a reasonable treatment option?","volume":"61","author":"Kennedy","year":"2018","journal-title":"Dis Colon Rectum."}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626041362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626041362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:06:57Z","timestamp":1790366817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626041362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0360301626041362"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.08.001","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"More for Some, Less for Others: Refining Treatment for Anorectal Cancers","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}